Frank Stokes is Chief Financial Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 39,551 shares of CSTL, which is worth approximately $840,854. The most recent transaction as insider was on Dec 10, 2023, when has been sold 2,386 shares (Common Stock) at a price of $20.17 per share, resulting in proceeds of $48,125. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.6K
0% 3M change
68.88% 12M change
Total Value Held $840,854

Frank Stokes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2023
SELL
Payment of exercise price or tax liability
$48,125 $20.17 p/Share
2,386 Reduced 5.69%
39,551 Common Stock
Dec 10 2023
BUY
Exercise of conversion of derivative security
-
8,170 Added 16.91%
40,135 Common Stock
Dec 09 2023
SELL
Payment of exercise price or tax liability
$86,105 $20.17 p/Share
4,269 Reduced 11.22%
33,767 Common Stock
Dec 09 2023
BUY
Exercise of conversion of derivative security
-
14,617 Added 27.76%
38,036 Common Stock
Apr 04 2023
BUY
Exercise of conversion of derivative security
$13,520 $3.38 p/Share
4,000 Added 14.59%
23,419 Common Stock
Dec 10 2022
SELL
Payment of exercise price or tax liability
$53,701 $22.32 p/Share
2,406 Reduced 11.49%
18,539 Common Stock
Dec 10 2022
BUY
Exercise of conversion of derivative security
-
8,170 Added 28.64%
20,356 Common Stock
May 12 2022
BUY
Exercise of conversion of derivative security
$13,520 $3.38 p/Share
4,000 Added 23.85%
12,775 Common Stock
Apr 26 2022
BUY
Grant, award, or other acquisition
-
1,114 Added 11.27%
8,775 Common Stock
Dec 10 2021
SELL
Payment of exercise price or tax liability
$36,265 $40.52 p/Share
895 Reduced 10.88%
7,330 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
-
2,000 Added 19.56%
8,225 Common Stock
Jun 17 2021
SELL
Open market or private sale
$92,929 $73.0 p/Share
1,273 Reduced 17.7%
5,920 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
$3,042 $2.39 p/Share
1,273 Added 15.04%
7,193 Common Stock
Jun 16 2021
SELL
Open market or private sale
$155,420 $73.07 p/Share
2,127 Reduced 26.43%
5,920 Common Stock
Jun 16 2021
BUY
Exercise of conversion of derivative security
$5,084 $2.39 p/Share
2,127 Added 20.91%
8,047 Common Stock
Jun 15 2021
SELL
Open market or private sale
$847,032 $73.02 p/Share
11,600 Reduced 66.21%
5,920 Common Stock
Jun 15 2021
BUY
Exercise of conversion of derivative security
$27,724 $2.39 p/Share
11,600 Added 39.84%
17,520 Common Stock
Jan 12 2021
SELL
Open market or private sale
$585,750 $78.1 p/Share
7,500 Reduced 65.87%
3,886 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$17,925 $2.39 p/Share
7,500 Added 39.71%
11,386 Common Stock
Jan 11 2021
SELL
Open market or private sale
$586,950 $78.26 p/Share
7,500 Reduced 65.87%
3,886 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$17,925 $2.39 p/Share
7,500 Added 39.71%
11,386 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$6,760 $3.38 p/Share
2,000 Added 33.98%
3,886 Common Stock
Nov 13 2020
SELL
Open market or private sale
$666,250 $51.25 p/Share
13,000 Reduced 87.33%
1,886 Common Stock
Nov 13 2020
BUY
Exercise of conversion of derivative security
$31,070 $2.39 p/Share
13,000 Added 46.62%
14,886 Common Stock
Nov 12 2020
SELL
Open market or private sale
$671,320 $51.64 p/Share
13,000 Reduced 87.33%
1,886 Common Stock

Also insider at

XGN
EXAGEN INC. Healthcare
FS

Frank Stokes

Chief Financial Officer
Friendswood, TX

Track Institutional and Insider Activities on CSTL

Follow CASTLE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL